April 29, 2026 LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
April 29, 2026 Flag Ship Acquisition Corp Receives Nasdaq Notification of Non-Compliance with Listing Rules